An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
SOPHiA GENETICS, a data-driven medicine leader, will announce its Q1 2024 financial results on May 7, 2024. A conference call discussing the results and business outlook will follow, webcast live on their Investor Relations website.
SOPHiA GENETICS, leader nella medicina basata sui dati, annuncerà i risultati finanziari del primo trimestre 2024 il 7 maggio 2024. Seguirà una teleconferenza per discutere i risultati e le prospettive aziendali, che sarà trasmessa in diretta sul sito web delle Relazioni con gli Investitori.
SOPHiA GENETICS, líder en medicina basada en datos, anunciará sus resultados financieros del primer trimestre de 2024 el 7 de mayo de 2024. Posteriormente, se realizará una conferencia telefónica para discutir los resultados y las perspectivas empresariales, que se retransmitirá en directo en su sitio web de Relaciones con Inversores.
데이터 기반 의학 분야의 선두주자인 SOPHiA GENETICS가 2024년 1분기 재무 결과를 2024년 5월 7일에 발표할 예정입니다. 이어서 결과 및 사업 전망에 대해 논의하는 컨퍼런스 콜이 있을 예정이며, 이는 투자자 관계 웹사이트에서 실시간 웹캐스트로 진행됩니다.
SOPHiA GENETICS, leader de la médecine basée sur les données, annoncera ses résultats financiers du premier trimestre 2024 le 7 mai 2024. Une conférence téléphonique discutant des résultats et des perspectives d'affaires suivra, diffusée en direct sur leur site web des Relations Investisseurs.
SOPHiA GENETICS, ein Vorreiter in der datengesteuerten Medizin, wird am 7. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekanntgeben. Anschließend findet ein Telefonkonferenzgespräch statt, in dem die Ergebnisse und die Geschäftsaussichten besprochen werden, welches live auf der Website für Investorenbeziehungen übertragen wird.
Positive
None.
Negative
None.
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
FAQ
When will SOPHiA GENETICS announce its financial results for Q1 2024?
SOPHiA GENETICS will announce its financial results for the first quarter of fiscal year 2024 on May 7, 2024.
What time will the conference call to discuss the financial results and business outlook start?
The conference call will start at 8:00 a.m. EDT / 2:00 p.m. CET on May 7, 2024.
Where can I watch the live webcast of the conference call?
The live webcast of the conference call can be accessed on the SOPHiA GENETICS Investor Relations website.
Will a replay of the conference call be available?
Yes, a replay of the conference call will be available on the SOPHiA GENETICS Investor Relations website after its completion.
sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based
